Cargando…

Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial

INTRODUCTION: The North Star Ambulatory Assessment (NSAA) tool is a key instrument for measuring clinical outcomes in patients with Duchenne muscular dystrophy (DMD). To gain a better understanding of the longitudinal utility of the NSAA, we evaluated NSAA data from a phase II trial of 120 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muntoni, Francesco, Guglieri, Michela, Mah, Jean K., Wagner, Kathryn R., Brandsema, John F., Butterfield, Russell J., McDonald, Craig M., Mayhew, Anna G., Palmer, Jeffrey P., Marraffino, Shannon, Charnas, Lawrence, Mercuri, Eugenio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397979/ https://www.ncbi.nlm.nih.gov/pubmed/35998119 http://dx.doi.org/10.1371/journal.pone.0272858

Ejemplares similares

Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy
por: Ayyar Gupta, Vandana, et al.
Publicado: (2023)

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials
por: Ricotti, Valeria, et al.
Publicado: (2016)

Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy
por: Muntoni, Francesco, et al.
Publicado: (2019)

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab
por: Sherlock, Sarah P., et al.
Publicado: (2022)

Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy
por: Mercuri, Eugenio, et al.
Publicado: (2016)

Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy
por: Sherlock, Sarah P., et al.
Publicado: (2022)

DMD Genotypes and Motor Function in Duchenne Muscular Dystrophy: A Multi-institution Meta-analysis With Implications for Clinical Trials
por: Muntoni, Francesco, et al.
Publicado: (2023)

Symptomatic therapy of Duchenne Muscular Dystrophy (DMD)
por: Rüdel, Reinhardt
Publicado: (2012)

Vascular therapy for Duchenne muscular dystrophy (DMD)
por: Thapa, Sangharsha, et al.
Publicado: (2023)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
por: Frank, Diane E., et al.
Publicado: (2020)

Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
por: Rodger, Sunil, et al.
Publicado: (2012)

Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping
por: REZAEI TAVIRANI, Mostafa, et al.
Publicado: (2017)

Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy
por: Hibma, Jennifer E., et al.
Publicado: (2023)

Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead
por: Heslop, Emma, et al.
Publicado: (2021)

Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy
por: Gartz, Melanie, et al.
Publicado: (2020)

Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL
por: Powell, Philip A., et al.
Publicado: (2021)

Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients
por: Laviola, Marianna, et al.
Publicado: (2018)

Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
por: Hind, Daniel, et al.
Publicado: (2017)

Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis
por: Tsaknakis, K., et al.
Publicado: (2022)

Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
por: Gapinske, Michael, et al.
Publicado: (2023)

Letter to the Editor: In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
por: Muntoni, Francesco, et al.
Publicado: (2023)

Medical management of muscle weakness in Duchenne muscular dystrophy
por: Rivera, Sarah R., et al.
Publicado: (2020)

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
por: Scaglioni, Dominic, et al.
Publicado: (2021)

Evaluating a Stone of Hope: ICER’s 2019 Review of Treatments for Duchenne Muscular Dystrophy
por: Brandsema, John Frederick
Publicado: (2020)

MON-LB050 Preliminary Results from the "Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy (DMD) (NCT 02571205)"
por: Wood, Claire, et al.
Publicado: (2019)

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls
por: Mendell, Jerry R., et al.
Publicado: (2021)

A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20
por: Mata López, Sara, et al.
Publicado: (2018)

Chronic Hypoxia Impairs Muscle Function in the Drosophila Model of Duchenne's Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2010)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Exonic rearrangements in DMD in Chinese Han individuals affected with Duchenne and Becker muscular dystrophies
por: Ling, Chao, et al.
Publicado: (2019)

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy
por: Wu, Jiangfen, et al.
Publicado: (2023)

Risk of Obstructive Sleep Apnea in Saudi Male Boys with Duchenne Muscular Dystrophy (DMD)
por: Bamaga, Ahmed, et al.
Publicado: (2023)

Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients
por: Dwianingsih, Ery Kus, et al.
Publicado: (2023)

Quantifying the burden of caregiving in Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2016)

Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy
por: Mercuri, Eugenio, et al.
Publicado: (2016)

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial
por: Servais, Laurent, et al.
Publicado: (2022)

Compliance to Care Guidelines for Duchenne Muscular Dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2015)

Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy
por: Wood, C. L., et al.
Publicado: (2019)

Suitability of external controls for drug evaluation in Duchenne muscular dystrophy
por: Goemans, Nathalie, et al.
Publicado: (2020)

Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy
por: Audhya, Ivana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vvmt48logvegr0j828cmjr0rog